... tier two and three cities?
Bristol-Myers Squibb India and AstraZeneca Pharma India Ltd have launched their new oral pill Saxagliptin to treat type2 diabetes in India, this was done sometimes in April 2010, it being a new med it would be doubtful that tier two & three cities this particular med would be prescribed.
I would presume that the same effect would be in the case of Januvia as this was launched sometimes during 2008.
Both meds were launched by multinational companies so it would be presumed that the medication would be expensive as compared to other anti diabetic meds available.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 9 Mar 2011 • 7 answers
Posted 23 Jul 2011 • 2 answers
Posted 4 Jan 2012 • 0 answers
Posted 6 Feb 2013 • 1 answer
Posted 25 Feb 2015 • 1 answer